Thomas Reinheckel Selected Research

Rheumatoid Arthritis

9/2012	Decreased arthritis severity in cathepsin L-deficient mice is attributed to an impaired T helper cell compartment.
1/2007	Emerging roles of cysteine cathepsins in disease and their potential as drug targets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Reinheckel Research Topics

Disease

37	Neoplasms (Cancer) 01/2023 - 03/2006
19	Breast Neoplasms (Breast Cancer) 03/2024 - 05/2006
15	Neoplasm Metastasis (Metastasis) 03/2024 - 05/2006
8	Carcinogenesis 03/2024 - 03/2006
6	Infections 11/2022 - 10/2010
6	Inflammation (Inflammations) 01/2016 - 03/2008
5	Alopecia (Baldness) 10/2017 - 12/2004
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 08/2008
4	Pancreatitis 05/2020 - 02/2010
4	Fibrosis (Cirrhosis) 01/2018 - 06/2006
4	Proteinuria 01/2018 - 05/2011
3	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 03/2012
3	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 03/2024 - 10/2012
3	Ischemia 01/2022 - 02/2005
3	Tics (Tic) 11/2019 - 09/2016
3	Arthritis (Polyarthritis) 12/2013 - 11/2011
3	Hyperplasia 05/2011 - 12/2004
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2007 - 04/2002
2	Multiple Sclerosis 01/2022 - 10/2017
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2022 - 01/2017
2	Pain (Aches) 01/2022 - 01/2016
2	Stroke (Strokes) 01/2022 - 01/2016
2	Hypoxia (Hypoxemia) 08/2021 - 12/2003
2	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2020 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 01/2015
2	Kidney Diseases (Kidney Disease) 01/2018 - 10/2011
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2017 - 01/2017
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2017 - 11/2003
2	Metaplasia 01/2016 - 01/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 06/2012
2	Wounds and Injuries (Trauma) 10/2014 - 05/2009
2	Rheumatoid Arthritis 09/2012 - 01/2007
2	Renal Insufficiency (Renal Failure) 03/2012 - 10/2011
2	Cardiomyopathies (Cardiomyopathy) 08/2010 - 06/2006
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Cognitive Dysfunction 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Periodontitis 01/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Epilepsy (Aura) 01/2022
1	Atrophy 08/2021
1	Triple Negative Breast Neoplasms 01/2021

Drug/Important Bio-Agent (IBA)

35	Peptide Hydrolases (Proteases)FDA Link 03/2024 - 04/2002
20	CathepsinsIBA 01/2021 - 03/2006
16	Cathepsin BIBA 01/2022 - 03/2006
16	Cathepsin LIBA 07/2020 - 04/2002
15	Cysteine (L-Cysteine)FDA Link 12/2020 - 04/2002
14	Cysteine Proteases (Cysteine Protease)IBA 11/2019 - 12/2004
12	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2009
9	EnzymesIBA 01/2022 - 03/2006
7	Cathepsin DIBA 03/2024 - 03/2008
5	ProteomeIBA 01/2018 - 02/2015
4	CeruletideIBA 05/2020 - 02/2010
4	Cathepsin ZIBA 10/2017 - 02/2010
3	Messenger RNA (mRNA)IBA 03/2024 - 06/2015
3	Cathepsin HIBA 08/2021 - 08/2010
3	Cathepsin CIBA 12/2020 - 03/2006
3	TrypsinogenIBA 05/2020 - 02/2010
3	Cathepsin KIBA 11/2019 - 09/2006
3	CollagenIBA 01/2018 - 08/2008
3	Peptides (Polypeptides)IBA 01/2017 - 08/2008
3	Protease Inhibitors (Protease Inhibitor)IBA 09/2016 - 10/2010
2	Phenobarbital (Luminal)FDA Link 10/2023 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
2	ProgranulinsIBA 01/2022 - 01/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 10/2020 - 04/2017
2	TrypsinIBA 05/2020 - 02/2010
2	Serine (L-Serine)FDA Link 11/2019 - 10/2013
2	Matrix Metalloproteinases (MMPs)IBA 11/2019 - 01/2015
2	Metalloproteases (Metalloproteinases)IBA 11/2019 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2017 - 09/2016
2	Cathepsin EIBA 01/2017 - 01/2012
2	Dynamins (Dynamin)IBA 11/2016 - 10/2011
2	CD2-associated proteinIBA 11/2016 - 10/2011
2	Interleukin-6 (Interleukin 6)IBA 02/2011 - 01/2002
2	CytokinesIBA 02/2011 - 10/2010
2	ChemokinesIBA 02/2011 - 08/2010
2	Amyloid beta-PeptidesIBA 08/2009 - 08/2008
2	Cadherins (E-Cadherin)IBA 05/2009 - 03/2006
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 03/2024
1	Selective Estrogen Receptor Modulators (SERM)IBA 10/2023
1	AminopeptidasesIBA 10/2023
1	Tamoxifen FDA LinkGeneric 10/2023
1	Pyruvic Acid (Pyruvate)IBA 01/2023
1	Silicon Dioxide (Silica)FDA LinkGeneric 11/2022
1	GranulinsIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Mitochondrial Processing PeptidaseIBA 01/2022
1	cathepsin SIBA 01/2022
1	Opiate AlkaloidsIBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 08/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 08/2021
1	Conditioned Culture MediaIBA 01/2021
1	Detergents (Detergent)IBA 12/2020
1	Cystatin BIBA 12/2020
1	leucyl-leucine-methyl esterIBA 12/2020

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2007
3	Transplantation 01/2021 - 01/2011
3	Drug Therapy (Chemotherapy) 11/2019 - 11/2009